| Logo | Name | Σ |
|---|---|---|
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3677 |
 | Greater Paris University Hospitals - AP-HP Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par … Sectors: Health | 2262 |
 | Orange Orange is here. Orange is one of the world’s leading telecommunications operators with revenues of 40.3 billion euros in 2024 and 127,000 employees worldwide at 31 December 2024, including 71,000 employees in France. The Group has a total customer base of 291 million customers worldwide at 31 December 2024, including 253 million mobile customers and 22 million fixed broadband customers. The Group is present in 26 countries. Orange is also a leading provider of global IT and telecommunication services to multinational companies under the brand Orange Business. In February 2023, the Group presented its strategic plan « Lead the future … Tags: CAC40 Sectors: Law Practice Telecoms | 6095 |
 | Inria The French national research institute for digital science and technology World-leading research and technological innovation are an integral part of its DNA. Inria's 3,500 researchers and engineers put their passion for digital technology to work in nearly 200 project teams, most of which are joint teams with our academic partners, including major research universities and the CNRS. They explore new fields, often in collaboration with different disciplines and industrial partners, with the aim of meeting ambitious challenges. As a technology institute, Inria supports the development of numerous software products, sometimes making a global impact via the opensource model. Because technology … Sectors: Research | 2180 |
 | Keyrus Keyrus: Unlocking the Full Potential of Data with a Human-Centric Approach As an international player in consulting and technology, Keyrus is committed to making sense of data by revealing its full potential, particularly from a human perspective. Our value proposition is built on diverse service groups: Automation & Artificial Intelligence: We provide our clients with the tools to enhance productivity and accuracy across their processes, allowing them to focus on higher-value work. Human-Centered Digital Experience: Customer relationships and employee engagement are two of the biggest contributors to business success. We help companies design and create seamless, multimodal digital experiences to … Sectors: IT services | 480 |
 | Leem The professional organization of drug companies operating in France. Leem, medication companies, brings together companies in the pharmaceutical industry in France. Created over 130 years ago, the Leem now has nearly 270 adhering companies, which have almost 98 % of the total medication turnover in France. The pharmaceutical industry employs 100,000 people in more than 150 trades, and has recruited 10,000 employees per year for 10 years. Each year, the pharmaceutical industry invests 12 % of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its R & AMP; D … Sectors: Startup accelerator & VC | 755 |
 | Assurance Maladie Working for health insurance is to give a new dimension to your job and act on a daily basis for the protection of our health system. Take part in a wide variety of projects in a benevolent setting and be proud to contribute to an essential mission: to act together, to protect each. For almost 80 years, health insurance has played a major role in the service of national solidarity. We are convinced that the key to the sustainability of the health system is a collective responsibility and lies in the strong involvement of each of its actors. Within this … Sectors: Insurance | 1621 |
 | Haute Autorité de Santé Official page of the High Authority for Health (HAS), independent public authority of a scientific nature HAS is an independent public authority which aims to contribute to the regulation of the health system by quality. Its missions in the fields of the evaluation of health products, professional practices, organization of care and public health, aim to provide all patients and users with sustainable and equitable access to as effective, safe and efficient care as possible. | 556 |
 | Institut Analgesia 1st foundation of pain research in France A major public health problem, chronic pain today affects 1 out of 5 adults, or more than 12 million French people. And as the therapeutic arsenal is both aging and insufficient, almost 2 thirds of patients believe that their pain is insufficiently controlled. Pain also has a very important impact on occupational health. Dorsal pain is the 1st cause of incapacity in the world and musculoskeletal disorders represent the 1st cause of occupational disease in France. The pain in itself impacts 88 million working days per year in France. Fighting pain is therefore … Sectors: Research | 184 |